Charles A. Boswell, Ph.D. - Publications

Affiliations: 
2004 Washington University, Saint Louis, St. Louis, MO 
Area:
PET agents for cancer imaging

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Mandikian D, Figueroa I, Oldendorp A, Rafidi H, Ulufatu S, Schweiger MG, Couch JA, Dybdal N, Joseph SB, Prabhu S, Ferl GZ, Boswell CA. Tissue Physiology of Cynomolgus Monkeys: Cross-Species Comparison and Implications for Translational Pharmacology. The Aaps Journal. 20: 107. PMID 30298434 DOI: 10.1208/S12248-018-0264-Z  0.56
2018 Mandikian D, Takahashi N, Lo AA, Li J, Eastham-Anderson J, Slaga D, Ho J, Hristopoulos M, Clark R, Totpal K, Lin K, Joseph SB, Dennis MS, Prabhu S, Junttila TT, ... Boswell CA, et al. Relative Target Affinities of T Cell-Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model. Molecular Cancer Therapeutics. PMID 29339550 DOI: 10.1158/1535-7163.Mct-17-0657  0.557
2015 Dickmann LJ, Yip V, Li C, Abundes J, Maia M, Young C, Stainton S, Hass PE, Joseph SB, Prabhu S, Boswell CA. Evaluation of Fluorophotometry to Assess the Vitreal Pharmacokinetics of Protein Therapeutics. Investigative Ophthalmology & Visual Science. 56: 6991-9. PMID 26513505 DOI: 10.1167/Iovs.15-17457  0.558
2015 Bumbaca Yadav D, Sharma VK, Boswell CA, Hotzel I, Tesar D, Shang Y, Ying Y, Fischer SK, Grogan JL, Chiang EY, Urban K, Ulufatu S, Khawli LA, Prabhu S, Joseph S, et al. Evaluating the use of antibody variable region (Fv) charge as a risk assessment tool for predicting typical cynomolgus monkey pharmacokinetics. The Journal of Biological Chemistry. PMID 26491012 DOI: 10.1074/Jbc.M115.692434  0.571
2011 Bumbaca D, Boswell CA, Mundo EE, Xin Y, Xiang H, Port RE, Schweiger MG, Stainton SL, Bagri A, Theil FP, Fielder PJ, Khawli LA, Shen BQ. Abstract 4588: Tumor distribution of anti-neuropilin-1 is affected by antibody dose level in a tumor xenograft mouse model Cancer Research. 71: 4588-4588. DOI: 10.1158/1538-7445.Am2011-4588  0.332
2010 Bumbaca D, Boswell CA, Xiang H, Port R, Schweiger M, Stainton S, Bagri A, Theil F, Fielder PJ, Khawli LA, Shen B. Abstract 696: Anti-NRP1 tumor uptake is impacted by normal tissue sinks in a tumor bearing mouse model Cancer Research. 70: 696-696. DOI: 10.1158/1538-7445.Am10-696  0.339
2006 Shen X, Boswell CA, Wong EH, Weisman GR, Anderson CJ, Tomellini SA. Investigation of copper-azamacrocyclic complexes by high-performance liquid chromatography. Biomedical Chromatography : Bmc. 20: 37-47. PMID 15954159 DOI: 10.1002/Bmc.525  0.506
2005 Boswell CA, McQuade P, Weisman GR, Wong EH, Anderson CJ. Optimization of labeling and metabolite analysis of copper-64-labeled azamacrocyclic chelators by radio-LC-MS. Nuclear Medicine and Biology. 32: 29-38. PMID 15691659 DOI: 10.1016/J.Nucmedbio.2004.09.004  0.517
2005 Woodin KS, Heroux KJ, Boswell CA, Wong EH, Weisman GR, Niu W, Tomellini SA, Anderson CJ, Zakharov LN, Rheingold AL. Kinetic inertness and electrochemical behavior of copper(II) tetraazamacrocyclic complexes: Possible implications for in vivo stability European Journal of Inorganic Chemistry. 4829-4833. DOI: 10.1002/Ejic.200500579  0.5
2004 Boswell CA, Sun X, Niu W, Weisman GR, Wong EH, Rheingold AL, Anderson CJ. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. Journal of Medicinal Chemistry. 47: 1465-74. PMID 14998334 DOI: 10.1021/Jm030383M  0.521
2002 Sun X, Wuest M, Weisman GR, Wong EH, Reed DP, Boswell CA, Motekaitis R, Martell AE, Welch MJ, Anderson CJ. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands. Journal of Medicinal Chemistry. 45: 469-77. PMID 11784151 DOI: 10.1021/Jm0103817  0.585
2001 Lewis MR, Boswell CA, Laforest R, Buettner TL, Ye D, Connett JM, Anderson CJ. Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3. Cancer Biotherapy & Radiopharmaceuticals. 16: 483-94. PMID 11789025 DOI: 10.1089/10849780152752083  0.501
2001 Boswell CA, Sun X, Wang M, Ramos B, Weisman GR, Wong EH, Anderson CJ. Relationship between reduction potential and in vivo stability of copper-azamacrocycle complexes Journal of Labelled Compounds and Radiopharmaceuticals. 44: S770-S772. DOI: 10.1002/Jlcr.25804401271  0.47
Show low-probability matches.